Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
17.11
-0.24 (-1.38%)
At close: Oct 29, 2025, 4:00 PM EDT
17.09
-0.02 (-0.12%)
After-hours: Oct 29, 2025, 5:20 PM EDT
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.15 billion as of October 29, 2025. Its market cap has increased by 10.00% in one year.
Market Cap
1.15B
Enterprise Value
1.05B
1-Year Change
10.00%
Ranking
Category
Stock Price
$17.11
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.15B, an increase of 2,097.39%. That is a compound annual growth rate of 38.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 1.17B | 8.99% |
| Dec 31, 2024 | 1.07B | 59.11% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
| May 18, 2016 | 52.40M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |